STAGE III DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Clinical trials for STAGE III DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough thyroid cancers: drug XL092 targets resistant tumors
Disease control Recruiting nowThis study tests a new drug called XL092 in people with advanced thyroid cancer that no longer responds to standard radioiodine therapy. The drug works by blocking a protein that helps cancer cells grow. Researchers want to see if it can slow or stop the cancer from spreading, an…
Matched conditions: STAGE III DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 26, 2026 05:44 UTC
-
Can your social life help you beat Cancer's aftermath?
Knowledge-focused Recruiting nowThis study follows 250 young adults (ages 18-39) recently diagnosed with cancer to see how their social relationships and physical activity change over time and affect their quality of life. Researchers will track hospitalizations, treatment details, exercise habits, and well-bei…
Matched conditions: STAGE III DIFFERENTIATED THYROID GLAND CARCINOMA AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC